A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2002
11/05/2002	US6476079 Devices for the delivery of drugs having antiprogestinic properties
11/05/2002	US6476078 Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
11/05/2002	US6476068 Platinum derivative pharmaceutical formulations
11/05/2002	US6476059 Use of polycyclic 2-aminothiazole systems for the treatment of obesity
11/05/2002	US6476043 Use of camptothecin derivatives, with reduced gastrointestinal toxicity
11/05/2002	US6476010 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of l-carnitine or salts
11/05/2002	US6476006 Compact form for oral administering; bone disorders
11/05/2002	US6476004 Pharmaceutical composition
11/05/2002	US6475997 Methods of stimulating phagocytosis
11/05/2002	US6475984 Administration of leptin
11/05/2002	US6475795 Use of hyaluronan in gene therapy
11/05/2002	US6475779 Polymeric gene delivery
11/05/2002	US6475542 Edible microcapsule and food containing the same
11/05/2002	US6475535 Hot fomentations
11/05/2002	US6475528 Preparation for regenerating collagen
11/05/2002	US6475526 Zinc containing compositions for anti-viral use
11/05/2002	US6475525 Oral preparations containing forskolin derivatives and process for producing pharmaceutical preparations
11/05/2002	US6475524 Composition of matter
11/05/2002	US6475523 Powders comprising anti-adherant materials for use in dry powder inhalers
11/05/2002	US6475521 Biphasic controlled release delivery system for high solubility pharmaceuticals and method
11/05/2002	US6475519 Oil-free pharmaceutical compositions containing cyclosporin A
11/05/2002	US6475518 Methods and compositions for treatment of disorders associated with chlamydia and similar bacterial infection
11/05/2002	US6475517 Method for preparing closed vesicles
11/05/2002	US6475516 Hydrogel loaded with liposomal therapeutic agent
11/05/2002	US6475515 Contrast medium that is to be encapsulated in the liposomes is metered such that 5 to 95% by weight of the contrast medium is present in unencapsulated form stabilization
11/05/2002	US6475514 Athletic patch
11/05/2002	US6475510 Process for manufacturing bite-dispersion tablets
11/05/2002	US6475507 Sustained release compositions and the process for their preparation
11/05/2002	US6475506 Infusion preparation
11/05/2002	US6475502 Kits containing cyanoacrylate compositions comprising an antimicrobial agent
11/05/2002	US6475495 Hyperbranched polymers or dendrimers containing a particular group, preparation process, use and compositions comprising them
11/05/2002	US6475494 In an oral dosage form, providing a combination product analgesically effective when administered orally, but which is aversive in addicts at the same dose or higher dose than prescribed; prevention of drug abuse, drug dependency
11/05/2002	US6475493 Controlled release pellet formulation
11/05/2002	US6475477 Radio-opaque polymer biomaterials
11/05/2002	US6475473 Perfume compositions
11/05/2002	US6475468 Modulated release particles for aerosol delivery
11/05/2002	US6475467 Medicinal aerosol formulations
11/05/2002	CA2324467C Formulations for protection of peg-interferon alpha conjugates
11/05/2002	CA2217047C Preparation of sodium chloride aerosol formulations
11/05/2002	CA2138925C Method of producing reconstituted lipoproteins
11/05/2002	CA2110166C Tableting of colestipol hydrochloride
11/05/2002	CA2049811C Stabilized solid chemical compositions
11/05/2002	CA1341396C Cyclosporin crystal form, processes for its production pharmaceutical compositions containing it and its use
11/04/2002	EP0904109A4 Targeting macromolecular prodrugs to t lymphocytes
10/2002
10/31/2002	WO2002086427A1 Metering method for particulate material
10/31/2002	WO2002086118A1 Compositions and methods to control bleeding
10/31/2002	WO2002085951A2 Water soluble, randomly substituted partial n-, partial o-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
10/31/2002	WO2002085949A1 Purification method of hydroxypropylmethyl cellulose phthalate
10/31/2002	WO2002085789A2 Magnesium di-pot assium edta complex and method of administration
10/31/2002	WO2002085737A1 Water-soluble container having at least two openings
10/31/2002	WO2002085447A2 Microprojection array having a beneficial agent containing coating
10/31/2002	WO2002085446A2 Microprojection array immunization patch and method
10/31/2002	WO2002085434A1 Injection device for administering rna
10/31/2002	WO2002085431A2 Method of delivering liquid through cerebral spinal pathway
10/31/2002	WO2002085428A2 Implantable osmotic pump
10/31/2002	WO2002085423A1 Biomaterials with bioactive coatings
10/31/2002	WO2002085422A1 Drug delivery matrices to enhance wound healing
10/31/2002	WO2002085419A2 Bifunctional-modified hydrogels
10/31/2002	WO2002085415A1 Non-digestible sugar-coated products and process
10/31/2002	WO2002085414A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
10/31/2002	WO2002085408A1 Method of production of insulin-containing oil-based preparation for oral
10/31/2002	WO2002085402A1 Methods and compositions for treating oral and eosophageal lesions
10/31/2002	WO2002085387A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
10/31/2002	WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002	WO2002085384A2 Lubricious coatings for substrates
10/31/2002	WO2002085371A1 Noninvasive method for treating cellulite through transdermal delivery of calcium channel blocker agents and medicament for use in such method
10/31/2002	WO2002085366A1 Aripiprazole oral solution
10/31/2002	WO2002085347A1 Preventive/remedial agent for inflammatory disease in oral-cavity mucosa and the like
10/31/2002	WO2002085344A1 Noninvasive methods for treating hemangiomas
10/31/2002	WO2002085338A2 Ipratropium formulation for pulmonary inhalation
10/31/2002	WO2002085337A1 Micellar drug delivery systems for hydrophobic drugs
10/31/2002	WO2002085336A1 Orodispersible effervescent tablets
10/31/2002	WO2002085335A1 A novel coating for a sustained release pharmaceutical composition
10/31/2002	WO2002085334A1 Medicinal tablet with prolonged release of the active principle
10/31/2002	WO2002085333A1 Gastric juice-resistant device for releasing mucoadhesive active substance excipients and method for producing this gastric juice-resistant device
10/31/2002	WO2002085332A1 A pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance and respective processes of producing same and a cup-shaped envelope of same
10/31/2002	WO2002085331A1 Fast disintegrating meloxicam tablet
10/31/2002	WO2002085330A1 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/31/2002	WO2002085329A1 Method for the continuous production of medicaments for inhalation
10/31/2002	WO2002085328A2 Method for producing an active ingredient concentrate, and an active ingredient concentrate
10/31/2002	WO2002085327A2 Use of nsaids for prevention and treatment of cellular abnormalities of the female reproductive tract
10/31/2002	WO2002085326A2 Large, porous particles produced controlling humidity during a spray drying process
10/31/2002	WO2002085311A2 Hcg formulation
10/31/2002	WO2002085309A2 Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent
10/31/2002	WO2002085304A2 Proliposomal drug delivery system
10/31/2002	WO2002085300A2 Methods of using interleukin-7 to modulate physiological processes in mammalian pulmonary fibroblasts
10/31/2002	WO2002085299A2 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002	WO2002085296A2 Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
10/31/2002	WO2002085292A2 Improved method for treating aberrant fibrotic tisue manifestations with topical calcium channel blocker preparations and improved composition for such treatment and improved method for the manufacture thereof
10/31/2002	WO2002085268A1 Disposal system for transdermal dosage form
10/31/2002	WO2002085255A1 Improved surgical stent and method for preventing occlusion of stented vessels and conduits after implantation of stents
10/31/2002	WO2002085248A2 Prostanoids augment ocular drug penetration
10/31/2002	WO2002085119A1 Intraoral delivery of nicotine for smoking cessation
10/31/2002	WO2002085113A1 Controlled release particles
10/31/2002	WO2002085112A1 A release pharmaceutical construct for gastric retention
10/31/2002	WO2002058750A3 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same
10/31/2002	WO2002051535A3 Preparation of microparticles having improved flowability
10/31/2002	WO2002051385A8 Solid dispersions of nitrate active principles
10/31/2002	WO2002051356A3 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections

1 ... 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 ... 2991